Real-Life Multicenter Experience of Venetoclax in Combination with Hypomethylating Agents in Previously Untreated Adult Patients with Acute Myeloid Leukemia in Greece.
Theodora ChatzilygeroudiIsmini DarmaniNatali El GkotmiPinelopi VryttiaStavroula DounaAnthi BouchlaVasiliki LabropoulouMaria KotsopoulouArgiris SymeonidisMaria PagoniVasiliki PappaSotirios G PapageorgiouPublished in: Journal of clinical medicine (2024)
Evidently, venetoclax-HMA yields high response rates and profound survival benefits in real life and has changed our approach to alternative chemotherapy options.